Navigation Links
New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
Date:11/9/2010

atients at risk for invasive fungal infections who develop severe systemic illness.
  • Bacterial, viral and other infections due to opportunistic pathogens.

  • The risks and benefits of treatment with certolizumab pegol should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection. Patients should be closely monitored for the development of signs and symptoms of infection during and after treatment with certolizumab pegol, including the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating therapy.Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, of which certolizumab pegol is a member. Certolizumab pegol is not indicated for use in pediatric patients.Serious and sometimes fatal infection due to bacterial, mycobacterial, invasive fungal, viral or other opportunistic pathogens has been reported in patients receiving TNF-blocking agents. Among opportunistic infections, tuberculosis, histoplasmosis, aspergillosis, candidiasis, coccidioidomycosis, listeriosis, and pneumocystosis were the most common.  Treatment with certolizumab pegol should not be initiated in patients with an active infection, including clinically important localized infections.  Certolizumab pegol should be discontinued if a patient develops a serious infection or sepsis.  Patients who develop a new infection during treatment with certolizumab pegol should be closely monitored, undergo a prompt and complete diagnostic workup appropriate for immunocompromised patients, and appropriate antimicrobial therapy should be initiated.  Appropriate empiric antifungal therapy should also be considered while a diagnostic workup is performed for patients who develop a serious systemic illness and reside or travel in regions where mycoses are ende
    '/>"/>

    SOURCE UCB
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
    2. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
    3. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
    4. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
    5. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
    6. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
    7. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
    8. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
    9. Marken Rapidly Responds to Global Supply Chain Security Measures
    10. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
    11. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/30/2014)... Oct. 30, 2014 /CNW/ - Atlantic Canadians will save ... between Canada,s provinces and territories ... President of the Canadian Generic Pharmaceutical Association (CGPA), said ... while speaking at the Atlantic Summit on Healthcare and ... which is being hosted by the Public Policy Forum ...
    (Date:10/30/2014)... 30, 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... technology platform company serving the pharmaceutical, biotechnology, and medical ... and the United States , ... the Tel Aviv area of ... WuXi,s broad platform of integrated R&D services to local ...
    (Date:10/30/2014)... , Oct. 30, 2014   ViaDerma, Inc. ... to bringing new products to market, has recently ... TetraStem. TetraStem is a topical liquid tetracycline-based antibiotic ... that can convert oral medication active ingredients into ... a first aid antibiotic to help prevent skin ...
    Breaking Medicine Technology:Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 2Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 3WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3
    ... K-V Pharmaceutical Company (NYSE:  KVa/KVb) announced today that it ... Administration ("FDA") of the successful completion of an inspection ... first product to market.  Under the Company,s Consent Decree, ... and facilities are expected to be required before K-V ...
    ... Inc. Promote PurCotton(R) Brand in Shenzhen -- SHENZHEN, China, Sept. 10 /PRNewswire-Asia/ -- ... ... --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
    Cached Medicine Technology:K-V Pharmaceutical Company Announces Completion of U.S. Food and Drug Administration Inspection and Approval to Return its First Product to Market 2K-V Pharmaceutical Company Announces Completion of U.S. Food and Drug Administration Inspection and Approval to Return its First Product to Market 3K-V Pharmaceutical Company Announces Completion of U.S. Food and Drug Administration Inspection and Approval to Return its First Product to Market 4K-V Pharmaceutical Company Announces Completion of U.S. Food and Drug Administration Inspection and Approval to Return its First Product to Market 5K-V Pharmaceutical Company Announces Completion of U.S. Food and Drug Administration Inspection and Approval to Return its First Product to Market 6K-V Pharmaceutical Company Announces Completion of U.S. Food and Drug Administration Inspection and Approval to Return its First Product to Market 7K-V Pharmaceutical Company Announces Completion of U.S. Food and Drug Administration Inspection and Approval to Return its First Product to Market 8Winner Medical and U.S. Cotton Inc. Promote PurCotton(R) Brand in Shenzhen 2Winner Medical and U.S. Cotton Inc. Promote PurCotton(R) Brand in Shenzhen 3Winner Medical and U.S. Cotton Inc. Promote PurCotton(R) Brand in Shenzhen 4Winner Medical and U.S. Cotton Inc. Promote PurCotton(R) Brand in Shenzhen 5Winner Medical and U.S. Cotton Inc. Promote PurCotton(R) Brand in Shenzhen 6Winner Medical and U.S. Cotton Inc. Promote PurCotton(R) Brand in Shenzhen 7Winner Medical and U.S. Cotton Inc. Promote PurCotton(R) Brand in Shenzhen 8
    (Date:10/31/2014)... In the first study of its kind, Rice University ... circuits that cause cancer cells to become metastatic. The ... allows cancer cells to both migrate and form new ... to new drugs that interfere with the genetic switches ... cells and circulating tumor cells -- two of the ...
    (Date:10/31/2014)... Daily Gossip writes in its Xtreme Fat Loss ... fastest fat loss program ever developed. It promises to provide ... There is no wonder after all that this has become ... new nutrition and workout fat loss program was created by ... According to the author of this fat loss system, the ...
    (Date:10/31/2014)... (PRWEB) October 31, 2014 With all ... one Midwest optometrist feels they may overlook one critical ... affect areas like concentration, school performance and even behavior. ... too brief to identify progressive vision problems, and to ... Mo., announces a new initiative: The Awesome Eyes Student ...
    (Date:10/31/2014)... 2014 (HealthDay News) -- Sleep apnea may make it hard ... parked your car or left your house keys, a small ... apnea showed that this ability -- called spatial memory -- ... sleep, even when other stages of sleep weren,t affected. REM ... typically occur. "We,ve shown for the first time that ...
    (Date:10/31/2014)... of four older Americans say that either they or ... treatment, according to the latest issue of The Gerontological ... ( PP&AR ), which goes on to show ... fail to honor patients, end-of-life health care wishes. , ... Issues and Options ," features 12 articles that present ...
    Breaking Medicine News(10 mins):Health News:Decoding the emergence of metastatic cancer stem cells 2Health News:Decoding the emergence of metastatic cancer stem cells 3Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Advance directives can benefit patients, families, and health care system 2
    ... ... Better , ... 2010 -- He,s no guru. And he’s not selling a philosophy, a religion, or telling ... Still the stories surrounding this young Croatian have spawned hundreds of thousands all over Europe ...
    ... it helps build strength and flexibility, aids relaxation, experts ... is safe for pregnant women, as long as they ... say. , "Women who are expecting can benefit greatly ... be aware of their limitations," orthopaedic surgeon and mom-to-be ...
    ... ... nasty germs has just become a little easier. If you’re like most of ... spraying everything is sight. Let’s face it -- no one likes germs. ... Arnot Thursday, May 27th at 7:00am (ET/PT), as they air on Lifetime Television. ...
    ... Highly anticipated Speed ... ... Trek Bicycle , the world leader in bicycle technology and innovation, officially launched its ... the backdrop of the Amgen Tour of California’s Stage 7 Time Trial in Los Angeles. ...
    ... ... software to Windows dedicated server & Windows VPS (virtual private server) hosting clients at ... customer service software and SmarterStats Web log analytics and SEO software. It is valued ... ...
    ... ... ... On this edition of The Balancing Act, we are bringing viewers some vitally important information about ... talk about a plan that can help make sure that your family is covered. , ...
    Cached Medicine News:Health News:Regular Guy "Braco" Healing Masses in Europe 2Health News:Yoga's Benefits Outweigh Risks for Pregnant Women 2Health News:O2 Media's Hit Morning Show ‘The Balancing Act' Welcomes Dr. Bob Arnot to the Program 2Health News:Trek Introduces Speed Concept Triathlon Bikes 2Health News:Trek Introduces Speed Concept Triathlon Bikes 3Health News:Trek Introduces Speed Concept Triathlon Bikes 4Health News:Dedicate Server and VPS Hosting Provider Company HostRightNow Technologies Partners with SmarterTools Inc. 2Health News:O2 Media's Hit Morning Show ‘The Balancing Act' Welcomes HSA Bank to the Program 2
    ... Rapid Plasma Reagin ... rapid detection and quantitative ... serum or plasma. Uses ... to detect reagin. Kits ...
    Latex agglutination slide test for the qualitative and semi-qualitative detection of antinuclear antibodies to aid in the diagnosis of systemic lupus erthyematosus....
    ... Rapid Plasma Reagin card ... detection and quantitative determination ... or plasma. Uses carbon ... detect reagin. Kits include ...
    Test for the quantitative determination of antideoxyribonuclease-B (ADNase-B) in serum....
    Medicine Products: